Chapter title |
Sex-Related Aspects of Biomarkers in Cardiac Disease
|
---|---|
Chapter number | 33 |
Book title |
Sex-Specific Analysis of Cardiovascular Function
|
Published in |
Advances in experimental medicine and biology, July 2018
|
DOI | 10.1007/978-3-319-77932-4_33 |
Pubmed ID | |
Book ISBNs |
978-3-31-977931-7, 978-3-31-977932-4
|
Authors |
Mingels, Alma M A, Kimenai, Dorien M, Alma M. A. Mingels, Dorien M. Kimenai, Mingels, Alma M. A., Kimenai, Dorien M. |
Abstract |
Biomarkers play an important role in the clinical management of cardiac care. In particular, cardiac troponins (cTn) and natriuretic peptides are the cornerstones for the diagnosis of acute myocardial infarction (AMI) and for the diagnosis of heart failure (HF), respectively. Current guidelines do not make a distinction between women and men. However, the commonly used "one size fits all" algorithms are topic of debate to improve assessment of prognosis, particularly in women. Due to the high-sensitivity assays (hs-cTn), lower cTn levels (and 99th percentile upper reference limits) were observed in women as compared with men. Sex-specific diagnostic thresholds may improve the diagnosis of AMI in women, though clinical relevance remains controversial and more trials are needed. Also other diagnostic aspects are under investigation, like combined biomarkers approach and rapid measurement strategies. For the natriuretic peptides, previous studies observed higher concentrations in women than in men, especially in premenopausal women who might benefit from the cardioprotective actions. Contrary to hs-cTn, natriuretic peptides are particularly incorporated in the ruling-out algorithms for the diagnosis of HF and not ruling-in. Clinical relevance of sex differences here seems marginal, as clinical research has shown that negative predictive values for ruling-out HF were hardly effected when applying a universal diagnostic threshold that is independent from sex or other risk factors. Apart from the diagnostic issues of AMI in women, we believe that in the future most sex-specific benefits of cardiac biomarkers can be obtained in patient follow-up (guiding therapy) and prognostic applications, fitting modern ideas on preventive and personalized medicine. |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 27 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 3 | 11% |
Student > Ph. D. Student | 3 | 11% |
Professor > Associate Professor | 3 | 11% |
Student > Master | 3 | 11% |
Researcher | 2 | 7% |
Other | 3 | 11% |
Unknown | 10 | 37% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 9 | 33% |
Immunology and Microbiology | 2 | 7% |
Biochemistry, Genetics and Molecular Biology | 2 | 7% |
Social Sciences | 2 | 7% |
Materials Science | 1 | 4% |
Other | 0 | 0% |
Unknown | 11 | 41% |